MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PRATT, W. B.
Right arrow Articles by ARONOW, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PRATT, W. B.
Right arrow Articles by ARONOW, L.

Molecular Pharmacology, Vol 3, 219-224, Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics

The Effect of Cortisol, Administered in Vivo, on the in Vitro Incorporation of DNA and RNA Precursors by Rat Thymus Cells

WILLIAM B. PRATT 1, STEVEN EDELMAN 1, and LEWIS ARONOW 1

1 Department of Pharmacology, Stanford University School of Medicine, Palo Alto, California 94304

Cortisol, administered in vivo, decreases the rate at which radioactive labeled deoxycytidine and uridine are incorporated into macromolecular material by rat thymus cells incubated in vitro. The degree of inhibition of uridine conversion to acid-insoluble material, observed after 3 hr of cortisol treatment, remains constant at both high and low levels of precursor specific activity, whereas the inhibition of deoxycytidine-3H incorporation observed using precursor of high specific activity is obliterated when the labeled precursor is diluted with large amounts of the nonradioactive compound. This observation is consonant with the hypothesis that one action of cortisol on rat thymocytes is to increase the intracellular pool of DNA precursors and not, as has been supposed, to inhibit the rate of DNA synthesis. Inhibition of RNA synthesis does seem to occur within a few hours after cortisol administration.

Note:
ACKNOWLEDGMENTS This work was supported by Grant CAO5672 from the National Cancer Institute, National Institutes of Health, and Public Health Service Training Grant GM322 from the Division of General Medical Sciences.

Submitted on November 17, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics